Below are the earnings highlights for Amneal Pharmaceuticals, Inc. (AMRX):
Earnings: -$31.08 million in Q4 vs. -$98.65 million in the same period last year.
EPS: -$0.10 in Q4 vs. -$0.40 in the same period last year.
Excluding items, Amneal Pharmaceuticals, Inc. reported adjusted earnings of $40.42 million or $0.12 per share for the period.
Analysts projected $0.15 per share
Revenue: $730.52 million in Q4 vs. $616.98 million in the same period last year.
For comments and feedback: editorial@rttnews.com